Global Carrier Screening market trends 2024, Forecast To 2033

The carrier screening market has undergone rapid growth in recent years, surging from $2.31 billion in 2023 to$2.7 billion in 2024 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period is attributed to the increasing awareness of genetic disorders, rising maternal age prompting family planning and pregnancy awareness, efforts aimed at preventing genetic diseases, public health initiatives, and heightened focus on inherited conditions. Looking ahead, the carrier screening market is expected to witness rapid growth, projected to reach $4.91 billion in 2028 at a compound annual growth rate (CAGR) of 16.1%. The forecasted growth is fueled by advancements in precision medicine, expanded panel offerings, the rise of consumer genomics and direct-to-consumer testing, focus on rare and ultra-rare diseases, government and insurance support, and the integration of pharmacogenomics. Major trends in the forecast period encompass advancements in genetic technologies, integration with prenatal testing methodologies, the rise of personalized medicine approaches, the provision of counseling and education services, and the consideration of ethical and legal implications.